A potent 5-HT4 agonist
Technical Support & Resources

Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

Tegaserod (maleate)

Item No. 14692

Product Insert (PDF)Safety Data Sheet (SDS) (PDF)
Technical Information
Formal Name
2-[(5-methoxy-1H-indol-3-yl)methylene]-N-pentyl-hydrazinecarboximidamide, 2Z-butenedioate
CAS Number
189188-57-6
Synonyms
  • SDZ-HTF 919
  • Zelnorm
Molecular Formula
C16H23N5O • C4H4O4
Formula Weight
417.5
Purity
≥98%
Formulation (Request formulation change)
A crystalline solid
Solubility(Learn about Variance in Solubility)
DMF: 25 mg/mlDMF:PBS (pH 7.2)(1:3): 0.03 mg/mlDMSO: 20 mg/ml
λmax
279, 316 nm
SMILES
COC(C=C1)=CC2=C1NC=C2/C=N/NC(NCCCCC)=N.OC(/C=C\C(O)=O)=O
InChi Code
InChI=1S/C16H23N5O.C4H4O4/c1-3-4-5-8-18-16(17)21-20-11-12-10-19-15-7-6-13(22-2)9-14(12)15;5-3(6)1-2-4(7)8/h6-7,9-11,19H,3-5,8H2,1-2H3,(H3,17,18,21);1-2H,(H,5,6)(H,7,8)/b20-11+;2-1-
InChi Key
CPDDZSSEAVLMRY-FEQFWAPWSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

Download most recent Certificate of Analysis for this product

    5 mg

    $81

    Add

    10 mg

    $128

    Add

    25 mg

    $239

    Add

    50 mg

    $395

    Add
    Product Description

    Tegaserod (maleate) is a potent agonist of the serotonin 4 receptor (5-HT4, Ki = 3.9-31 nM).1,2 As 5-HT4 receptors are associated with cholinergic nerves lining the colon, tegaserod (maleate) stimulates colonic motility and transit in vivo, in both healthy and diseased gastrointestinal tracts.3,4 However, it lacks selectivity, since it also acts as an antagonist for the 5-HT2A, 5-HT2B, and 5-HT2C receptors (Ki = 32, 3.9, and 100 nM, respectively).5,6,4 It is a weak agonist of 5-HT3 (Ki ≤ 10 μM).7

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Long, D.D., Armstrong, S.R., Beattie, D.T., et al. Discovery, oral pharmacokinetics and in vivo efficacy of velusetrag, a highly selective 5-HT4 receptor agonist that has achieved proof-of-concept in patients with chronic idiopathic constipation. Bioorg. Med. Chem. Lett. 22(19), 6048-6052 (2012).

    2. Hedner, E., Sjögren, M., Frändberg, P.A., et al. Brominated cyclodipeptides from the marine sponge Geodia barretti as selective 5-HT ligands. J. Nat. Prod. 69(10), 1421-1424 (2006).

    3. Nguyen, A., Camilleri, M., Kost, L.J., et al. SDZ HTF 919 stimulates canine colonic motility and transit in vivo. J. Pharmacol. Exp. Ther. 280(3), 1270-1276 (1997).

    4. Tack, J., Camilleri, M., Chang, L., et al. Systematic review: Cardiovascular safety profile of 5-HT4 agonists developed for gastrointestinal disorders. Aliment. Pharmacol. Ther. 35(7), 745-767 (2012).

    5. Beattie, D.T., Smith, J.A.M., Marquess, D., et al. The 5-HT4 receptor agonist, tegaserod, is a potent 5-HT2B receptor antagonist in vitro and in vivo. Br. J. Pharmacol. 143(5), 549-560 (2004).

    6. McCullough, J.L., Armstrong, S.R., Hegde, S.S., et al. The 5-HT2B antagonist and 5-HT4 agonist activities of tegaserod in the anaesthetized rat. Pharmacol. Res. 53(4), 353-358 (2006).

    7. Lemaître, S., Lepailleur, A., Bureau, R., et al. Novel antagonists of serotonin-4 receptors: Synthesis and biological evaluation of pyrrolothienopyrazines. Bioorg. Med. Chem. 17(6), 2607-2622 (2009).